MLV & Co. Upgrades Cytokinetics (CYTK) to Buy
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $66.82 +1.91%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 2
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 2
Join SI Premium – FREE
MLV & Co. upgraded Cytokinetics (NASDAQ: CYTK) from Hold to Buy with a price target of $9.00.
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $3.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cytokinetics to Announce First Quarter Results on May 8, 2024
- Wells Fargo Upgrades Packaging Corp. of America (PKG) to Overweight
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
